BML, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,035 JPY | +0.50% |
|
+4.37% | +1.17% |
ETFs positioned on BML, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.83% | 22 M€ | +3.37% | - | |
| 0.10% | 19 M€ | +5.60% | ||
| 0.02% | 70 M€ | +16.33% | ||
| 0.02% | 9,760 M€ | +16.01% | ||
| 0.02% | 4,929 M€ | +16.00% | ||
| 0.02% | 17 M€ | +15.35% | - | |
| 0.01% | 746 M€ | -.--% | - | |
| 0.01% | 140,441 M€ | +16.33% | - | |
| 0.01% | 63,295 M€ | +16.36% | - | |
| 0.01% | 20,360 M€ | +15.16% | ||
| 0.00% | 32 M€ | +0.82% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +3.43% | - |
BML, INC. is mainly engaged in the clinical testing as well as related business. The Testing segment engages in the commissioned work of clinical testing. The Medical Information Systems segment is engaged in the manufacturing and sales of system equipment for medical institutions, as well as provision of medical information service.
Calendar
07/08/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3,035
JPY
Average target price
2,967
JPY
Spread / Average Target
-2.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.17% | 755M | |
| -15.77% | 8.49B | |
| +59.28% | 4.08B | |
| -43.01% | 2.42B | |
| -9.98% | 2.42B | |
| -3.24% | 2.33B | |
| -2.10% | 2.01B | |
| -20.57% | 1.53B | |
| -40.57% | 1.26B | |
| +9.11% | 1.07B |
- Stock Market
- Equities
- 4694 Stock
- Funds and ETFs BML, Inc.